161 related articles for article (PubMed ID: 35367767)
1. The potential applications of traditional Chinese medicine in Parkinson's disease: A new opportunity.
Chen J; Xu J; Huang P; Luo Y; Shi Y; Ma P
Biomed Pharmacother; 2022 May; 149():112866. PubMed ID: 35367767
[TBL] [Abstract][Full Text] [Related]
2. Research on the signaling pathways related to the intervention of traditional Chinese medicine in Parkinson's disease:A literature review.
Jin X; Dong W; Chang K; Yan Y
J Ethnopharmacol; 2024 May; 326():117850. PubMed ID: 38331124
[TBL] [Abstract][Full Text] [Related]
3. Antioxidative role of Traditional Chinese Medicine in Parkinson's disease.
Muhammad F; Liu Y; Zhou Y; Yang H; Li H
J Ethnopharmacol; 2022 Mar; 285():114821. PubMed ID: 34838943
[TBL] [Abstract][Full Text] [Related]
4. The Potential Application of Chinese Medicine in Liver Diseases: A New Opportunity.
Fu K; Wang C; Ma C; Zhou H; Li Y
Front Pharmacol; 2021; 12():771459. PubMed ID: 34803712
[TBL] [Abstract][Full Text] [Related]
5. The estrogen receptor β-PI3K/Akt pathway mediates the cytoprotective effects of tocotrienol in a cellular Parkinson's disease model.
Nakaso K; Tajima N; Horikoshi Y; Nakasone M; Hanaki T; Kamizaki K; Matsura T
Biochim Biophys Acta; 2014 Sep; 1842(9):1303-12. PubMed ID: 24768803
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.
Yang Y; Gehrke S; Haque ME; Imai Y; Kosek J; Yang L; Beal MF; Nishimura I; Wakamatsu K; Ito S; Takahashi R; Lu B
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13670-5. PubMed ID: 16155123
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
[TBL] [Abstract][Full Text] [Related]
8. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
9. Network Pharmacology-Based and Molecular Docking-Based Analysis of Suanzaoren Decoction for the Treatment of Parkinson's Disease with Sleep Disorder.
Liu YY; Yu LH; Zhang J; Xie DJ; Zhang XX; Yu JM
Biomed Res Int; 2021; 2021():1752570. PubMed ID: 34660782
[TBL] [Abstract][Full Text] [Related]
10. The pathogenesis and treatment mechanism of Parkinson's disease from the perspective of traditional Chinese medicine.
Chen P; Zhang J; Wang C; Chai YH; Wu AG; Huang NY; Wang L
Phytomedicine; 2022 Jun; 100():154044. PubMed ID: 35338993
[TBL] [Abstract][Full Text] [Related]
11. The Chinese Herb
Gu Y; Wang T; Chen J; Zhou Z; Wang Y; Chen J; Liu N; Jiang Z
J Integr Neurosci; 2020 Jun; 19(2):333-340. PubMed ID: 32706197
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
13. Salidroside ameliorates Parkinson's disease by inhibiting NLRP3-dependent pyroptosis.
Zhang X; Zhang Y; Li R; Zhu L; Fu B; Yan T
Aging (Albany NY); 2020 May; 12(10):9405-9426. PubMed ID: 32432571
[TBL] [Abstract][Full Text] [Related]
14. Traditional Chinese medicine for modern treatment of Parkinson's disease.
Han L; Xie YH; Wu R; Chen C; Zhang Y; Wang XP
Chin J Integr Med; 2017 Aug; 23(8):635-640. PubMed ID: 28108911
[TBL] [Abstract][Full Text] [Related]
15. [Advance in studies on pathological mechanism of Parkinson's disease and traditional Chinese medicine experiments in prevention and treatment of Parkinson's disease].
Xiong P; Chen X; Zhang N
Zhongguo Zhong Yao Za Zhi; 2012 Mar; 37(5):686-91. PubMed ID: 22693916
[TBL] [Abstract][Full Text] [Related]
16. Punicalagin's Protective Effects on Parkinson's Progression in Socially Isolated and Socialized Rats: Insights into Multifaceted Pathway.
Salem HA; Abu-Elfotuh K; Alzahrani S; Rizk NI; Ali HS; Elsherbiny N; Aljohani A; Hamdan AME; Chellasamy P; Abdou NS; Gowifel AMH; Darwish A; Ibrahim OM; Abd Elmageed ZY
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896179
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin protects against rotenone-induced cytotoxicity: Involvement of mitophagy and the AMPK/SIRT1/PGC1α pathway.
Wang H; Dou S; Zhu J; Shao Z; Wang C; Xu X; Cheng B
Neuropeptides; 2021 Jun; 87():102134. PubMed ID: 33639357
[TBL] [Abstract][Full Text] [Related]
18. Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease.
Yalçınkaya N; Haytural H; Bilgiç B; Özdemir Ö; Hanağası H; Küçükali Cİ; Özbek Z; Akcan U; İdrisoğlu HA; Gürvit H; Tüzün E
Neurosci Lett; 2016 Feb; 615():72-7. PubMed ID: 26806867
[TBL] [Abstract][Full Text] [Related]
19. Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson's Disease.
Zhang M; He Q; Chen G; Li PA
Neurodegener Dis; 2020; 20(2-3):73-83. PubMed ID: 33176317
[TBL] [Abstract][Full Text] [Related]
20. Protective Effect of Tocotrienol on In Vitro and In Vivo Models of Parkinson's Disease.
Matsura T
J Nutr Sci Vitaminol (Tokyo); 2019; 65(Supplement):S51-S53. PubMed ID: 31619646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
